Bayer SA
153.9 FTEThe score of Bayer shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -20 % Equity -53 % Total assets -53 % Headcount (avg FTE) -28 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bayer's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jun 2026
- Year ended 31 Dec 2024filed on 16 Jun 2025
- Year ended 31 Dec 2023filed on 10 Jun 2024
- Year ended 31 Dec 2022filed on 06 Jun 2023
- Year ended 31 Dec 2021filed on 09 Jun 2022
Bayer's financial analysis
- Solvency99.6%sector median: 48.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bayer
Bayer's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0404.754.571
- VAT number
- BE0404754571
- Peppol
- Registered · 0208:0404754571 · as of 09 Nov 2026
- Legal form
- SA
- Incorporated
- 20 Jul 1961
- Registered office
- 1831 Machelen (Brab.)
- Size
- Medium · 153.9 FTE
- Latest accounts
- 2025 · filed on 24 Jun 2026
- Activity
- Manufacture of other organic basic chemicals (NACE 20140)
Bayer (SA) has been based in Machelen (Brab.) since 1961, active in: manufacture of other organic basic chemicals. For 2025, it reports revenue of €175.2m, a net profit of €3.43m and equity of €5.53bn. With 153.9 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 99.6%, above the median of its sector (48.8%).
Companies similar to Bayer
Companies in the same business, of comparable size and area, outside its group.
- Acros Organics Wholesale of pharmaceutical and medical goods Geel · balance sheet €1.91bn
- Evonik Oxeno Antwerpen NV Manufacture of other organic basic chemicals Antwerp · balance sheet €142.2m
- Ajinomoto Omnichem Manufacture of basic pharmaceutical products Wetteren · balance sheet €476.3m
- Pfizer Manufacture of pharmaceutical preparations Ixelles · balance sheet €377.4m
- Novartis Manufacturing Manufacture of pharmaceutical preparations Puurs-Sint-Amands · balance sheet €285.2m
- PHOENIX Pharma Belgium Manufacture of pharmaceutical preparations Woluwe-Saint-Lambert · balance sheet €235.4m
- PolyPeptide Manufacture of basic pharmaceutical products Braine-l'Alleud · balance sheet €331.7m
- SERB Wholesale of pharmaceutical and medical goods Ixelles · balance sheet €159.3m
Frequently asked questions about Bayer
What is the revenue of Bayer?
According to the 2025 annual accounts filed with the NBB, the revenue of Bayer amounts to 175,154,790 €.
What is the VAT number of Bayer?
In Belgium, the VAT number is the company number prefixed with BE: BE0404754571 for Bayer, if the company is VAT-registered. Its company number (CBE) is 0404.754.571.
Where is the registered office of Bayer?
According to the CBE register, the registered office of Bayer is in 1831 Machelen (Brab.).
What is the equity of Bayer?
At the close of the 2025 financial year, the equity of Bayer amounts to 5,534,189,801 €, a solvency of 99.6% of total assets.
How many people work at Bayer?
153.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Bayer?
The register lists 4 active mandates at Bayer. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bayer
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →